Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

34.340
+0.2200.64%
Volume:4.31M
Turnover:148.61M
Market Cap:142.10B
PE:43.76
High:34.840
Open:34.100
Low:34.040
Close:34.120
52wk High:44.000
52wk Low:16.200
Shares:4.14B
HK Float Shares:4.14B
Volume Ratio:1.83
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.785
ROE:10.50%
ROA:5.89%
PB:2.78
PE(LYR):43.76
PS:6.23

Loading ...

WuXi Biologics Receives UK MHRA GMP Certification for Ophthalmic Biologic Manufacturing

Reuters
·
Jan 13

Hong Kong Stocks Movement | CRO Concept Stocks Lead Gains with WUXI APPTEC (02359) Forecasting Doubled Net Profit; Sector Poised for "Davis Double Play"

Stock News
·
Jan 13

Wuxi Biologics (Cayman) Stock Rallies 1.4% in Hong Kong

Dow Jones
·
Jan 12

WUXI BIO (02269): Total Integrated Projects Reach Record High of 945 in 2025, Bispecific/Multispecific Antibody Revenue More Than Doubles

Stock News
·
Jan 12

Market Insights: Focus on TSMC Earnings This Week; Commercial Space Emerges as Strongest Theme

Stock News
·
Jan 12

Wuxi Biologics Unveils Scaled Global CRDMO Platform Advancing Biologics Development

Reuters
·
Jan 11

Akari Therapeutics Highlights 2025 Progress and Plans Clinical Transition in 2026

Reuters
·
Jan 09

BRIEF-BlackRock's Long Position In WuXi Biologics Decreases To 5.61% On Jan 5 From 6.14% - HKEX

Reuters
·
Jan 09

BlackRock's Long Position in WuXi Biologics Decreases to 5.61% on Jan 5 From 6.14% - HKEX

THOMSON REUTERS
·
Jan 09

Wuxi Biologics (Cayman) Stock Rises 1.7% in Hong Kong

Dow Jones
·
Jan 09

Whitehawk Therapeutics Unveils ADC Pipeline and Platform Innovations in Corporate Presentation

Reuters
·
Jan 08

BUZZ-Australia's Canyon Resources rises to nearly 3-month high on Cameroon mine update

Reuters
·
Jan 08

Is WuXi Biologics (SEHK:2269)'s New Procurement Certification a Signal on Supply Chain Resilience?

Simply Wall St.
·
Jan 08

BRIEF-Blackrock's Long Position In Wuxi Biologics (Cayman) Increases To 6.14% On Jan 2, HKEX Shows

Reuters
·
Jan 07

WuXi Biologics CEO to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 07

BlackRock's Long Position in WuXi Biologics (Cayman) Increases to 6.14% on Jan 2 From 5.32% - HKEX

THOMSON REUTERS
·
Jan 07

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

Dow Jones
·
Jan 06

Wuxi Biologics (Cayman) Stock Rises 3.0% in Hong Kong

Dow Jones
·
Jan 05

WuXi Biologics Achieves ISO 20400 Certification for Sustainable Procurement

Reuters
·
Jan 05

Wuxi Biologics (Cayman) Stock Advances 3.5% in Hong Kong

Dow Jones
·
Jan 02